AGP Executive Report
Last update: 9 hours agoMedicare Price Transparency: CMS rolled out new rules to make it easier to find, compare, and report healthcare pricing and coverage details before patients get care. Affordability Pressure: A KFF analysis says a Trump-era-style one-time $90 Medicare payment may not offset rising costs, since the Part B premium increase could eat most of it. Drug Safety: Authorities ordered recalls of nine batches of the heart medicine Lowplat Plus after adulteration was found. Behavioral Health Funding: The Cherokee Nation won a $12M federal behavioral health grant over four years to expand coordinated care for people facing homelessness, serious mental illness, and substance use disorders. Public Health Alerts: Utah warned of fatal overdoses tied to illegal kratom and “cat’s claw” products containing dangerous semi-synthetic compounds. UK AI Device Oversight: The UK will continuously monitor AI-enabled medical devices after approval, backing all 44 commission recommendations. Clinical Updates: BioVentrix reported first patients treated in its RELIVE trial for Revivent heart-failure therapy in Georgia. Global Health Workforce: Malaysia’s health ministry will assess how long-distance postings affect medical officers’ families, including relationships and divorce rates.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
